Newborn Screening Market Size, Share and Forecast 2019-2026

SKU: DMD368 | Last Updated On: Dec 05 2019 | No. of Pages: 199 | Available Formats

Newborn Screening Market By Product (Assay Kits, Enzymatic Assay Kits, DNA Assay Kits, Immunoassay Kits, Others, Instruments, Mass Spectrometer, Pulse Oximetry, Hearing Screening Devices, Laparoscope, Retinoscope, Ultrasound Machine, Others), By Test Type (Blood Test, Cardiac Test, Urine Test, Hearing Test, Others), By Application (Critical congenital heart disease, Blood Spot Test, Hearing Disability, Sickle Cell Disease, Maple Syrup Urine Disease, Thyroid Disorder, Others), By End-User (Hospitals, Diagnostic Centers, Maternity & Specialty Clinics, Others), and Region - Global Forecast to 2026

Market Overview
 

Newborn screening is the practice of testing newborn for certain disorders such as phenylketonuria (PKU), cystic fibrosis, sickle cell disease, critical congenital heart disease, hearing loss, and others. This testing is typically performed before the baby leaves the hospital. Early detection and treatment can help prevent intellectual and physical disabilities and life-threatening illnesses in newborn.

 

The global newborn screening market size was valued at $ YY billion in 2018 and is estimated to reach $ YY billion by 2026, at a CAGR of YY% during the forecast period (2019-2026).

Market Dynamics

The newborn screening market growth is driven by several factors such as rising neonatal population base, increase in number of cases of congenital diseases in newborns. For instance, according to UNICEF data, globally, 2.5 million children died in the first month of life in 2017 alone, approximately 7,000 neonatal deaths every day, most of which occurred in the first week. About 1 million dying on the first day and close to 1 million dying within the next six days due to lack of skilled care and screening of the babies. To reduce the death count, several efforts are being taken by organizations such as the WHO, CDC, Healthy Newborn Network, etc., to educate parents for the possible disorders and their diagnostic procedures. North American agencies have also ordered 100% screening of all children born in private sector hospitals.

 

In addition, increasing healthcare awareness, benefits offered by newborn screening programs, and technological advancements in screening, and increasing government funding and support are also driving the growth of the newborn screening market globally. For instance, the WHO implemented a program to safeguard the health of children globally, in which numerous policies and initiatives have been taken by the U.S. Department of Health and Human Services Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC), Japan’s Society of Obstetrics and Gynecology (JSOG), UK (PEACH), and advocacy groups.

 

However, lack of improved healthcare infrastructure and trained professionals, and socioeconomic barriers are some of the major factors restraining the growth of the global newborn screening market.

 

Market Segmentation

On the basis of product, the market has been segmented into assay kits and instruments. The assay kits segment is further sub-segmented into enzymatic assay kits, DNA assay kits, immunoassay kits, and others. Among these, the immunoassay kits segment accounted for the largest market share in 2018 as immunoassay is a primary test used in screening and estimated to grow significantly over the forecast period (2019-2026). The instruments segment has been further divided into Mass Spectrometer, Pulse Oximetry, Hearing Screening Devices, Laparoscope, Retinoscope, Ultrasound Machine, and Others.

 

By application, the blood spot test dominated the global newborn screening market accounting in 2018. The collection of blood from newborn’s heel within 24-48 hours of birth on the screening card for diagnosis of over 50 conditions is termed as heel stick or dried blood spot test (DBS). These screening cards are labeled using unique codes and contain no additional identity information. Autisms, Lymphomas and leukemia and many other metabolic conditions can be diagnosed through this test. The card used for testing is provided free in North America as a plan to promote higher procedure volume.

 

Critical Congenital Heart Disease (CCHD) is one of the commonly occurring disorders, which is screened using the pulse oximeter based technology. It is estimated that 18 out of 10,000 infants suffer from CCHD, which may lead to death if undetected. Growth of this segment is anticipated to affect the newborn screening market substantially over the forecast period.

Geographical Analysis

The North America is dominating the global Newborn Screening market with highest market size in 2018 and estimated to hold the largest market share over the forecast period (2019-2026). The U.S. is leading the North America newborn screening market due to rising prevalence of congenital disorders. According to CDC in 2017, more than five million babies born annually are screened for various possible conditions. In 2017, number of infant deaths was about 22,335 and the leading causes of infant deaths were congenital malformations, deformations and chromosomal abnormalities. Conditions for screening were provided through extensive research by the American College of Medical Genetics (ACMG) under the supervision of the U.S. Department of Health and Human Services (HHS). Recently, ACMG has deviated from the traditional screening criteria and added new conditions to the list. Newborn screening program is diligently followed in all the states of North America. In addition, to create awareness, health departments of the states in U.S. have published free data and created websites that are expected to help parents to cope better with these conditions.

 

The Asia Pacific newborn screening market is growing at the highest CAGR during the forecast period (2019-2026) due to rising awareness programs and quality assurance of newborn diagnostic procedures in the developing economies of Korea, China, Taiwan, India and Sri Lanka. Improving infrastructure and healthcare plans and the availability of new opportunities for expansion are expected to play a major role in driving demand over the forecast period.

 

The Middle East region is also contributing to the rising growth of the newborn screening market. For instnace, as part of the National Newborn Screening Program, over 295,000 babies born in Qatar have been screened for metabolic and endocrine disorders, including rare diseases, Of these, 958 babies have been diagnosed with a rare disorder or genetic condition. Qatar was the first country in the region to establish a national newborn screening program, which was implemented in December 2003.

 

Competitive Landscape
 

Some of the major players of the global ECMO system market include Covidien Plc., AB SCIEX, Bio Rad Laboratories, Agilent Technologies, Masimo Corporation, Natus Medical, Trivitron Healthcare, PerkinElmer Inc, GE Life Sciences, and ZenTech S.A.

 

The key players are adopting various strategies such new product developments, mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market. For instance,

 

In October 2018, Trivitron’s Labsystems Diagnostics Oy, a leading brand that develops and manufactures high-quality diagnostic tests for clinical laboratories and physicians, expanded its portfolio on advancing newborn screening (NBS) by launching six new high-quality NBS products at ISNS 2018, Slovakia.

 

In February 2018, Sema4, a health information company providing advanced genomic testing, launched Sema4 Natalis, a supplemental newborn screening test designed to detect 193 childhood-onset diseases or disorders so parents can gain early insight into their baby's health.

 

In October 2018, LifeCell International, launched “RightStart”, the world’s first Integrated DNA testing for Newborn Screening to detect over 50 medical conditions. This technology has been proven to be more accurate than current screening methods and has also been found to drastically reduce the false-positive reporting thereby avoiding unnecessary follow-up tests and anxiety of the parents.

 

Why Purchase the Report?

  • Visualize the composition of the newborn screening in terms of product type, application, test type, and end-user highlighting the key commercial assets and players.

  • Identify commercial opportunities in newborn screening market by analyzing trends and co-development deals.

  • Excel data sheet with thousands of data points of newborn screening market - level 4/5 segmentation.

  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

  • Product mapping in excel for the key product of all major market players

· 

Target Audience

  • Service Providers/ Buyers

  • Industry Investors/Investment Bankers

  • Education & Research Institutes

  • Research Professionals

  • Emerging Companies

  • Manufacturers         

 

Related Reports:

Blood Screening Market

Drug Screening Market

 

 

Table of Contents

  1. Global Newborn Screening Market Methodology and Scope

    1. Research Methodology

    2. Research Objective and Scope of the Report

  2. Global Newborn Screening Market – Market Definition and Overview

  3. Global Newborn Screening Market – Executive Summary

    1. Market Snippet by Modality

    2. Market Snippet by Product

    3. Market Snippet by Test type

    4. Market Snippet by Application

    5. Market Snippet by End-User

  4. Global Newborn Screening Market – Market Dynamics

    1. Market Impacting Factors

      1. Drivers

      2. Restraints

      3. Opportunity

      4. Impact Analysis

  5. Global Newborn Screening Market – Industry Analysis

    1. Porter's Five Forces Analysis

    2. Regulatory Analysis

    3. Supply Chain Analysis

    4. Pricing Analysis

  6. Global Newborn Screening Market – By Product

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment

      2. Market Attractiveness Index, By Product Segment

    2. Assay Kits*
      1. Enzymatic Assay Kits*
        1. Introduction

        2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

      2. DNA Assay Kits
      3. Immunoassay Kits
      4. Others
    3. Instruments
      1. Mass Spectrometer
      2. Pulse Oximetry
      3. Hearing Screening Devices
      4. Laparoscope
      5. Retinoscope
      6. Ultrasound Machine
      7. Others
  7. Global Newborn Screening Market – By Test Type

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type Segment

      2. Market Attractiveness Index, By Test Type Segment

    2. Blood Test*
      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

    3. Cardiac Test
    4. Urine Test
    5. Hearing Test
    6. Others
  8. Global Newborn Screening Market – By Application

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      2. Market Attractiveness Index, By Application Segment

    2. Critical congenital heart disease (CCHD)*

      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

    3. Blood Spot Test
    4. Hearing Disability
    5. Sickle Cell Disease
    6. Maple Syrup Urine Disease
    7. Thyroid Disorder
    8. Others
  9. Global Newborn Screening Market – By End-User

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment

      2. Market Attractiveness Index, By End-User Segment

    2. Hospitals*
      1. Introduction

      2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

    3. Diagnostic Centers
    4. Maternity & Specialty Clinics
    5. Others
  10. Global Newborn Screening Market – By Region

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

      2. Market Attractiveness Index, By Region

    2. North America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. U.S.

        2. Canada

        3. Mexico

    3. Europe

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Germany

        2. U.K.

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

    4. South America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Brazil

        2. Argentina

        3. Rest of South America

    5. Asia Pacific

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. China

        2. India

        3. Japan

        4. Australia

        5. Rest of Asia Pacific

    6. Middle East and Africa

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

  11. Global Newborn Screening Market – Competitive Landscape

    1. Competitive Scenario

    2. Market Positioning/Share Analysis

    3. Mergers and Acquisitions Analysis

  12. Company Profiles

    1. Covidien Plc.*
      1. Company Overview

      2. Product Portfolio and Description

      3. Key Highlights

      4. Financial Overview

    2. AB SCIEX
    3. Bio Rad Laboratories
    4. Agilent Technologies
    5. Masimo Corporation
    6. Natus Medical
    7. Trivitron Healthcare
    8. PerkinElmer Inc
    9. GE Life Sciences
    10. ZenTech S.A.
  13. Global Newborn Screening Market – Premium Insights

  14. Global Newborn Screening Market – DataM

    1. Appendix

    2. About Us and Services

    3. Contact Us

List of Tables and Figures

List of Tables

Table 1        Global Newborn Screening Market Value, By Product, 2018,2022 & 2026 ($ Million)

Table 2        Global Newborn Screening Market Value, By Test Type, 2018,2022 & 2026 ($ Million)

Table 3        Global Newborn Screening Market Value, By Application, 2018,2022 & 2026 ($ Million)

Table 4        Global Newborn Screening Market Value, By End-User, 2018,2022 & 2026 ($ Million)

Table 5        Global Newborn Screening Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 6        Global Newborn Screening Market Value, By Product, 2018,2022 & 2026 ($ Million)

Table 7        Global Newborn Screening Market Value, By Product, 2017-2026 ($ Million)

Table 8       Global Newborn Screening Market Value, By Test Type, 2018,2022 & 2026 ($ Million)

Table 9        Global Newborn Screening Market Value, By Test Type, 2017-2026 ($ Million)

Table 10      Global Newborn Screening Market Value, By Application, 2018,2022 & 2026 ($ Million)

Table 11      Global Newborn Screening Market Value, By Application, 2017-2026 ($ Million)

Table 12      Global Newborn Screening Market Value, By End-User, 2018,2022 & 2026 ($ Million)

Table 13      Global Newborn Screening Market Value, By End-User, 2017-2026 ($ Million)

Table 14      Global Newborn Screening Market Value, By Region, 2018,2022 & 2026 ($ Million)

Table 15      Global Newborn Screening Market Value, By Region, 2017-2026 ($ Million)

Table 16      North America Newborn Screening Market Value, By Product, 2017-2026 ($ Million)

Table 17      North America Newborn Screening Market Value, By Test Type, 2017-2026 ($ Million)

Table 18      North America Newborn Screening Market Value, By Application, 2017-2026 ($ Million)

Table 19      North America Newborn Screening Market Value, By End-User, 2017-2026 ($ Million)

Table 20     North America Newborn Screening Market Value, By Country, 2017-2026 ($ Million)

Table 21      South America Newborn Screening Market Value, By Product, 2017-2026 ($ Million)

Table 22      South America Newborn Screening Market Value, By Test Type, 2017-2026 ($ Million)

Table 23      South America Newborn Screening Market Value, By Application, 2017-2026 ($ Million)

Table 24      South America Newborn Screening Market Value, By End-User, 2017-2026 ($ Million)

Table 25      South America Newborn Screening Market Value, By Country, 2017-2026 ($ Million)

Table 26      Europe Newborn Screening Market Value, By Product, 2017-2026 ($ Million)

Table 27      Europe Newborn Screening Market Value, By Test Type, 2017-2026 ($ Million)

Table 28     Europe Newborn Screening Market Value, By Application, 2017-2026 ($ Million)

Table 29      Europe Newborn Screening Market Value, By End-User, 2017-2026 ($ Million)

Table 30     Europe Newborn Screening Market Value, By Country, 2017-2026 ($ Million)

Table 31      Asia-Pacific Newborn Screening Market Value, By Product, 2017-2026 ($ Million)

Table 32      Asia-Pacific Newborn Screening Market Value, By Test Type, 2017-2026 ($ Million)

Table 33      Asia-Pacific Newborn Screening Market Value, By Application, 2017-2026 ($ Million)

Table 34      Asia-Pacific Newborn Screening Market Value, By End-User, 2017-2026 ($ Million)

Table 35      Asia-Pacific Newborn Screening Market Value, By Country, 2017-2026 ($ Million)

Table 36      Middle East & Africa Newborn Screening Market Value, By Product, 2017-2026 ($ Million)

Table 37      Middle East & Africa Newborn Screening Market Value, By Test Type, 2017-2026 ($ Million)

Table 38     Middle East & Africa Newborn Screening Market Value, By Application, 2017-2026 ($ Million)

Table 39      Middle East & Africa Newborn Screening Market Value, By End-User, 2017-2026 ($ Million)

Table 40     Covidien Plc.: Overview

Table 41      Covidien Plc.: Product Portfolio

Table 42      Covidien Plc.: Key Developments

Table 43      AB SCIEX: Overview

Table 44      AB SCIEX: Product Portfolio

Table 45      AB SCIEX: Key Developments

Table 46      Bio Rad Laboratories: Overview

Table 47      Bio Rad Laboratories: Product Portfolio

Table 48     Bio Rad Laboratories: Key Developments

Table 49      Agilent Technologies: Overview

Table 50      Agilent Technologies: Product Portfolio

Table 51      Agilent Technologies: Key Developments

Table 52      Masimo Corporation: Overview

Table 53      Masimo Corporation: Product Portfolio

Table 54      Masimo Corporation: Key Developments

Table 55      ZenTech S.A.: Overview

Table 56      ZenTech S.A.: Product Portfolio

Table 57      ZenTech S.A.: Key Developments

Table 58      Natus Medical: Overview

Table 59      Natus Medical: Product Portfolio

Table 60     Natus Medical: Key Developments

Table 61      Trivitron Healthcare: Overview

Table 62      Trivitron Healthcare: Product Portfolio

Table 63      Trivitron Healthcare: Key Developments

Table 64      PerkinElmer Inc: Overview

Table 65      PerkinElmer Inc: Product Portfolio

Table 66      PerkinElmer Inc: Key Developments

Table 67      GE Life Sciences: Overview

Table 68     GE Life Sciences: Product Portfolio

Table 69      GE Life Sciences: Key Developments

List of Figures

Figure 1      Global Newborn Screening Market Share, By Product, 2018 & 2026 (%)

Figure 2      Global Newborn Screening Market Share, By Test Type, 2018 & 2026 (%)

Figure 3      Global Newborn Screening Market Share, By Application, 2018 & 2026 (%)

Figure 4      Global Newborn Screening Market Share, By End-User, 2018 & 2026 (%)

Figure 5      Global Newborn Screening Market Share, By Region, 2018 & 2026 (%)

Figure 6      Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 7      Global Newborn Screening Market Y-o-Y Growth, By Product, 2018-2026 (%)

Figure 8      Assay Kits: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 9      Instruments: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 10    Global Newborn Screening Market Y-o-Y Growth, By Test Type, 2018-2026 (%)

Figure 11     Blood Test: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 12    Cardiac Test: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 13    Urine Test: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 14    Hearing Test: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 15    Others: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 16    Global Newborn Screening Market Y-o-Y Growth, By Application, 2018-2026 (%)

Figure 17    Critical congenital heart disease (CCHD) : Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 18    Hearing Disability: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 19    Sickle Cell Disease: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 20    Maple Syrup Urine Disease: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 21    Thyroid Disorder: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 22    Blood Spot Test: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 23    Others: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 24    Global Newborn Screening Market Y-o-Y Growth, By End-User, 2018-2026 (%)

Figure 25    Hospitals: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 26    Diagnostic Centers: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 27    Maternity & Specialty Clinics: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 28    Others: Global Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 29    Global Newborn Screening Market Y-o-Y Growth, By Region, 2018-2026 (%)

Figure 30    North America Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 31    North America Newborn Screening Market Share, By Product, 2018 & 2026 (%)

Figure 32    North America Newborn Screening Market Share, By Test Type, 2018 & 2026 (%)

Figure 33    North America Newborn Screening Market Share, By Application, 2018 & 2026 (%)

Figure 34    North America Newborn Screening Market Share, By End-User, 2018 & 2026 (%)

Figure 35    North America Newborn Screening Market Share, By Country, 2018 & 2026 (%)

Figure 36    South America Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 37    South America Newborn Screening Market Share, By Product, 2018 & 2026 (%)

Figure 38    South America Newborn Screening Market Share, By Test Type, 2018 & 2026 (%)

Figure 39    South America Newborn Screening Market Share, By Application, 2018 & 2026 (%)

Figure 40    South America Newborn Screening Market Share, By End-User, 2018 & 2026 (%)

Figure 41    South America Newborn Screening Market Share, By Country, 2018 & 2026 (%)

Figure 42    Europe Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 43    Europe Newborn Screening Market Share, By Product, 2018 & 2026 (%)

Figure 44    Europe Newborn Screening Market Share, By Test Type, 2018 & 2026 (%)

Figure 45    Europe Newborn Screening Market Share, By Application, 2018 & 2026 (%)

Figure 46    Europe Newborn Screening Market Share, By End-User, 2018 & 2026 (%)

Figure 47    Europe Newborn Screening Market Share, By Country, 2018 & 2026 (%)

Figure 48    Asia-Pacific Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 49    Asia-Pacific Newborn Screening Market Share, By Product, 2018 & 2026 (%)

Figure 50    Asia-Pacific Newborn Screening Market Share, By Test Type, 2018 & 2026 (%)

Figure 51    Asia-Pacific Newborn Screening Market Share, By Application, 2018 & 2026 (%)

Figure 52    Asia-Pacific Newborn Screening Market Share, By End-User, 2018 & 2026 (%)

Figure 53    Asia-Pacific Newborn Screening Market Share, By Country, 2018 & 2026 (%)

Figure 54    Middle East & Africa Newborn Screening Market Value, 2017-2026 ($ Million)

Figure 55    Middle East & Africa Newborn Screening Market Share, By Product, 2018 & 2026 (%)

Figure 56    Middle East & Africa Newborn Screening Market Share, By Test Type, 2018 & 2026 (%)

Figure 57    Middle East & Africa Newborn Screening Market Share, By Application, 2018 & 2026 (%)

Figure 58    Middle East & Africa Newborn Screening Market Share, By End-User, 2018 & 2026 (%)

Figure 59    Covidien Plc.: Financials

Figure 60    AB SCIEX: Financials

Figure 61    Bio Rad Laboratories: Financials

Figure 62    Agilent Technologies: Financials

Figure 63    Masimo Corporation: Financials

Figure 64    ZenTech S.A.: Financials

Figure 65    Natus Medical: Financials

Figure 66    Trivitron Healthcare: Financials

Figure 67    PerkinElmer Inc: Financials

Figure 68    GE Life Sciences: Financials

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your FREE SAMPLE PROPOSAL with a single click!